LBA3 Transarterial chemoembolization (TACE) with or without lenvatinib (len) + pembrolizumab (pembro) for intermediate-stage hepatocellular carcinoma (HCC): Phase III LEAP-012 study

J. Llovet, R.S. Finn, Z. Ren, Yiying Guo, Guiyan Han, Haiyan Lin, Jie Zheng, Sadahisa Ogasawara, H. Li, Jeong Ho Kim, Huanyu Zhao, C. Li, David C. Madoff, R. Mark Ghobrial, Anthony B. El-Khoueiry, Arndt Vogel, Xiao‐Xia Peng, K. Mody, L. Dubrovsky, M. Kudo